Skip to main content

Day: June 18, 2020

Tonix Pharmaceuticals and Southern Research Announce Expansion of COVID-19 Vaccine Collaboration

Plan to Produce Blueprint of How the Human Immune System Responds to Infection Caused by SAR-CoV-2, the Virus that Causes COVID-19Results Expected to Support Tonix’s Anticipated Regulatory Filings for TNX-1800, a Live Replicating Virus Vaccine Designed to Elicit T Cell Immunity in Addition to AntibodiesNEW YORK, June 18, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today an expansion of its strategic collaboration with Southern Research to include a study of T cell immune responses to SARS-CoV-2 in volunteers who have recovered or remain asymptomatic after exposure to COVID-19.  The research is part of an ongoing and broader collaboration between Tonix and Southern Research to develop and conduct animal testing of Tonix’s...

Continue reading

Discovery Extends Higher-Grade Mineralization & Expands Drill Program at its Cordero Project

TORONTO, June 18, 2020 (GLOBE NEWSWIRE) — Discovery Metals Corp. (TSX-V: DSV, OTCQX: DSVMF) (“Discovery” or the “Company”) is pleased to announce results from eight diamond drill holes completed at its flagship Cordero project (“Cordero” or “the Project”) located in Chihuahua State, Mexico. The holes are part of a Phase 1 diamond core drilling program that commenced in September 2019. The goal of this program is to define a high-margin project with scale that retains excellent leverage to rising metal prices. Drill holes for this current release were focused on defining and extending the higher-grade mineralized footprint in the northern corridor along the north-east trend.Highlight intercepts include:0.7 metres (“m”) averaging 2,489 grams per tonne (“g/t”) silver equivalent (“AgEq”)1 in hole C20-326 from 303.1 m (comprised of 2,470...

Continue reading

IAMGOLD Intersects 10.5 m at 10.5 g/t Au Confirming the West Extension of the Mineralization of the Nelligan Project

THIS PRESS RELEASE CANNOT BE DISTRIBUTED TO US PRESS WIRE SERVICES FOR BROADCAST USE IN THE UNITED STATESMONTREAL, June 18, 2020 (GLOBE NEWSWIRE) — Vanstar Mining Resources (“Vanstar” or the Company) today announced initial assay results from its 2020 exploration diamond drilling program completed at its Nelligan joint venture project (IAMGOLD Corporation: 75%, Vanstar: 25%), located 60 kilometres southwest of Chibougamau, Quebec, Canada. The Company is reporting assay results from six (6) diamond drill holes totaling 3,717 metres completed as part of the 2020 drilling program. Assays are pending from a further three (3) completed drill holes totaling 1,278 metres.The assay results reported herein are provided in Table 1 below and include the following highlights:Download the drill hole plan map (PNG) – Download the results...

Continue reading

IAMGOLD intersecte 10,5 m à 10,5 g/t Au confirmant l’extension ouest de la minéralisation aurifère du Projet Nelligan

CE COMMUNIQUÉ NE PEUT PAS ÊTRE DISTRIBUÉ AUX SERVICES DE FIL DE PRESSE AMÉRICAINS POUR FINS DE DIFFUSION AUX ÉTATS-UNISMONTRÉAL, 18 juin 2020 (GLOBE NEWSWIRE) — IAMGOLD Corporation (« IAMGOLD » ou la « Société ») annonce les premiers résultats dans le cadre de son programme de forage d’exploration au diamant de 2020 réalisé à son projet en coentreprise, Nelligan, (IAMGOLD Corporation : 75 %, Vanstar: 25 %), situé à 60 kilomètres au sud-ouest de Chibougamau (Québec), au Canada. La Société indique des résultats d’analyse d’un programme de 6 (six) forages au diamant totalisant 3 717 mètres réalisés dans le cadre du programme de forage de 2020. Les résultats de trois (3) trous de forage supplémentaires totalisant 1 278 mètres sont attendus.Les résultats d’analyse sont fournis au tableau 1 ci-dessous et comprennent les principaux...

Continue reading

Lee Enterprises reports second quarter results

Solid revenue and adjusted EBITDA performance despite COVID-19Berkshire Hathaway refinanced all Lee debt with 25-year term, attractive rate and no covenantsClosed strategic acquisition of BH Media Group, nearly doubling our audience size and revenueExpect to achieve $100 million in cost synergies by end of FY2021DAVENPORT, Iowa, June 18, 2020 (GLOBE NEWSWIRE) — Lee Enterprises, Incorporated (NYSE: LEE), a leading provider of high quality, trusted, local news, information and a major platform for advertising in 77 markets, today reported second quarter fiscal 2020 financial results(1) for the period ended March 29, 2020.The discussion below reflects operating results of Lee including (i) our actual GAAP results, which reflect a full quarter and year to date period of Legacy Lee(2) results and two weeks of results of BHMG(2) and Buffalo(2),...

Continue reading

Scorpio Tankers Inc. Announces an Update on Daily TCE Rates

MONACO, June 18, 2020 (GLOBE NEWSWIRE) — Scorpio Tankers, Inc. (NYSE: STNG) (the “Company”) announced today an update on daily TCE rates.Below is a summary of the estimated average daily Time Charter Equivalent (“TCE”) revenue (see definition below) and duration of contracted pool activities (voyages and time charters) for the Company’s vessels as of today for the quarters ending June 30, 2020 and September 30, 2020.(1) TCE revenue, a Non-IFRS measure, is vessel revenues less voyage expenses (including bunkers and port charges). TCE revenue is included herein because it is a standard shipping industry performance measure used primarily to compare period-to-period changes in a shipping company’s performance irrespective of changes in the mix of charter types (i.e., spot charters, time charters, and pool charters),...

Continue reading

Leading US health insurance company selects eGain to modernize member service

eGain AI Knowledge solution will improve customer experience by empowering thousands of contact center agents with easy conversational guidance and process adherence capabilitySUNNYVALE, Calif., June 18, 2020 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), the leading provider of customer engagement solutions, today announced that a leading US health insurer selected its award-winning eGain AI Knowledge solution.Health insurance customer service, with its broad range of customer issues and stringent compliance requirements, is very challenging. According to Accenture, healthcare ranks 18th among 20 sectors in their NPS (Net Promoter Score) assessment across industries.Noting that their member service reps struggle through voluminous, often conflicting documents to resolve customer queries on the phone, the client sought out a knowledge...

Continue reading

InfuSystem to Join FTSE Russell 2000® Index

Rochester Hills, Michigan, June 18, 2020 (GLOBE NEWSWIRE) — InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today its addition to the FTSE Russell 2000® Index, following the Russell US Index’s Annual Reconstitution, effective after the market closes on June 26, 2020.Richard DiIorio, chief executive officer of InfuSystem, said, “We are pleased to be included in the Russell 2000® Index, the most widely followed benchmark for small-cap companies. This is an important milestone for InfuSystem as it will increase our visibility among leading institutional investors. We are excited about our solid operational and financial performance and look forward...

Continue reading

MediPharm Labs Reports First Quarter 2020 Results, Clears Path for International Growth

BARRIE, Ontario, June 18, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and derivative products, today announced its financial results for the three months ended March 31, 2020. The Company also provided an update on the build out of its global Good Manufacturing Practices (“GMP”) certified production platforms and new international medicinal, wellness and adult use-recreational revenue streams.“MediPharm Labs has proudly evolved from our beginning stages to today, capitalizing on a multi-jurisdictional GMP-certified manufacturing footprint to further develop a diversified international customer portfolio with multiple product streams suitable for lawful medicinal, wellness and...

Continue reading

Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy Capability

Company acquires property adjacent to its Canton, Massachusetts live viral drug substance development and manufacturing facility to increase campus footprint and build out advanced therapy capabilityAdvanced therapy CDMO drug substance manufacturing services expected to be available beginning in 2023Expansion will enable molecule-to-market CDMO services in viral vector and gene therapy utilizing Emergent’s integrated network with development services and drug product manufacturing to be offered out of its Gaithersburg and Rockville, Maryland facilities, respectively   GAITHERSBURG, Md., June 18, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions (NYSE: EBS) today announced that it will further strengthen its contract development and manufacturing (CDMO) capabilities by expanding into viral vector and gene therapy. The company will invest...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.